Sangamo Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Sangamo Therapeutics, Inc. (SGMO) is 62.18M

According to Sangamo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 62.18M. This represents a change of -55.56% compared to the average of 139.91M of the last 4 quarters.

Sangamo Therapeutics, Inc. (SGMO) Historical Enterprise Value (quarterly & annually)

How has SGMO Enterprise Value performed in the past?

The mean historical Enterprise Value of Sangamo Therapeutics, Inc. over the last ten years is 715.03M. The current 62.18M Enterprise Value has changed 769.55% with respect to the historical average. Over the past ten years (40 quarters), SGMO's Enterprise Value was at its highest in in the December 2020 quarter at 2.12B. The Enterprise Value was at its lowest in in the June 2024 quarter at 68.61M.

Sangamo Therapeutics, Inc. (SGMO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sangamo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sangamo Therapeutics, Inc. (SGMO) Average Enterprise Value

How has SGMO Enterprise Value performed in the past?

The current Enterprise Value of Sangamo Therapeutics, Inc. (SGMO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sangamo Therapeutics, Inc. (SGMO) Enterprise Value vs. Peers

How is SGMO’s Enterprise Value compared to its peers?

Sangamo Therapeutics, Inc.’s Enterprise Value is less than C4 Therapeutics, Inc. (340.91M), less than Insight Molecular Diagnostics Inc. (120.89M), less than OmniAb, Inc. (269.30M), less than Codexis, Inc. (269.51M), less than Armata Pharmaceuticals, Inc. (628.83M), less than Milestone Pharmaceuticals Inc. (177.67M), greater than Rani Therapeutics Holdings, Inc. (45.40M), less than Innate Pharma S.A. (145.48M), greater than Molecular Partners AG (40.49M), greater than Invivyd, Inc. (-46792714.00),

Build a custom stock screener for Sangamo Therapeutics, Inc. (SGMO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sangamo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sangamo Therapeutics, Inc. (SGMO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sangamo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.